Gen-Wealth Partners’s GSK GSK Stock Holding History

Gen-Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.97K	Hold	90	–	–	﹤0.01%	591
2025 Q4	$4.41K	Hold	90	–	–	﹤0.01%	575
2025 Q3	$3.88K	Hold	90	–	–	﹤0.01%	582
2025 Q2	$3.46K	Hold	90	–	–	﹤0.01%	539
2025 Q1	$3.49K	Hold	90	–	–	﹤0.01%	525
2024 Q4	$3.04K	Hold	90	–	–	﹤0.01%	560
2024 Q3	$3.33K	Hold	90	–	–	﹤0.01%	575
2024 Q2	$3.46K	Hold	90	–	–	﹤0.01%	553
2024 Q1	$3.86K	Buy	+90	New	+$3.71K	﹤0.01%	534

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Gen-Wealth Partners's GSK Position: Q1 2026 in Review

Gen-Wealth Partners held its GSK (GSK) position steady in Q1 2026 at 90 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #591.

Gen-Wealth Partners first reported a position in GSK in Q1 2024 and has held it in 9 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Gen-Wealth Partners held 90 shares of GSK worth $4.97K as of Q1 2026.
Gen-Wealth Partners left its GSK share count unchanged in Q1 2026.
GSK made up ﹤0.01% of Gen-Wealth Partners's portfolio in Q1 2026, its #591 holding.
Gen-Wealth Partners first reported a position in GSK in Q1 2024 and has held it in 9 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Gen-Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.